Yuanyan Liu

3.8k citations
77 papers · 2.8k indexed · 1 hit paper · h-index 28

Yuanyan Liu

74 papers receiving 2.7k citations

Hit Papers

PI3K/AKT pathway as a key link modulates the multidrug re...6032020202620222024200400600

Peers

Yuanyan Liu
Comparison fields: 5 of 140
  • Pharmacology 263
  • Complementary and alternative medicine 221
  • Biochemistry 156
  • Molecular Biology 1.3k
  • Cancer Research 285
Replace Xiangchun Shen with:
Xiangchun Shen China
Min Ho Han South Korea
Su Hyun Hong South Korea
Saleh A. Almatroodi Saudi Arabia
Hua Yu China
Ghulam Jilany Khan China
Hao Cui China
Amjad Ali Khan Saudi Arabia
Chandrasekharan Guruvayoorappan India
Xiaobin Jia China
Yuanyan Liu relative to Xiangchun Shen China Xiangchun Shen's profile →
Citations per field
00.5×1.5×
Xiangchun Shen · 1×
Citations per year

Countries citing papers authored by Yuanyan Liu

Since Specialization
Citations

This map shows the geographic impact of Yuanyan Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuanyan Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuanyan Liu more than expected).

Fields of papers citing papers by Yuanyan Liu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yuanyan Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuanyan Liu. The network helps show where Yuanyan Liu may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Yuanyan Liu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Yuanyan Liu Line = papers co-authored together Yuanyan Liu links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20253
2 20250
3 20251
4 202417
5 20241
6 202418
7 20241
8 202321
9 202349
10 202260
11 202211
12 202279
13 20223
14 202139
15 201818
16 201731
17 20176
18 2015250
19 20148
20 200944

About Yuanyan Liu

Yuanyan Liu is a scholar working on Complementary and alternative medicine, Pharmacology and Molecular Biology, having authored 77 papers that have together received 2.8k indexed citations. Recurring topics across this work include Natural product bioactivities and synthesis (16 papers), Traditional Chinese Medicine Analysis (9 papers), Phytochemistry and Biological Activities (8 papers), Natural Compounds in Disease Treatment (7 papers), Ginseng Biological Effects and Applications (7 papers), Extracellular vesicles in disease (6 papers), Pharmacological Effects of Natural Compounds (5 papers) and Nanoplatforms for cancer theranostics (5 papers). The work is most often cited by research in Pharmacology (263 citations), Complementary and alternative medicine (221 citations) and Biochemistry (156 citations). Yuanyan Liu has collaborated with scholars based in China, Hong Kong and United States. Frequent co-authors include Cheng Lü, Zhiwen Cao, Youwen Chen, Yurong Song, Guangzhi Liu, Siyu Zhao, Rui Liu, Wen Li, Aiping Lü and Zhangchi Ning. Their work appears in journals such as Journal of Biological Chemistry, SHILAP Revista de lepidopterología and Chemical Engineering Journal.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026